GENECENTRIC THERAPEUTICS, INC.
Profile
Company Names
GENECENTRIC THERAPEUTICS, INC.
GENECENTRIC DIAGNOSTICS, INC.
Addresses
100 CAPITOLA DRIVE, SUITE 275, DURHAM, NC 27713
280 SOUTH MANGUM STREET, SUITE 350, DURHAM, NC 27701
Phone Numbers
(919) 973-6544
(919) 215-5962
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2011
State Incorporated:
DELAWARE
Total Amount Raised:
$21,555,973.00
Number of Funding Rounds:
7
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
7
2025-06-04
$1,999,967.00
$5,000,000.00
$3,000,033.00
Equity
6
2022-09-08
$2,500,000.00
$3,500,000.00
$1,000,000.00
Debt
5
2021-09-22
$4,500,000.00
$7,500,000.00
$3,000,000.00
Equity
4
2020-12-29
$1,200,000.00
$1,200,000.00
$0.00
Debt
3
2016-12-22
$6,105,996.00
$8,605,992.00
$2,499,996.00
Equity
2
2013-06-19
$5,000,010.00
$5,000,010.00
$0.00
Equity
1
2011-09-02
$250,000.00
$250,000.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
MYLA
LAI-GOLDMAN
EXECUTIVE OFFICER, DIRECTOR
ARNOLD
LEVINE
DIRECTOR
ELLEN
LUBMAN
DIRECTOR
MICHAEL
MILBURN
EXECUTIVE OFFICER, DIRECTOR
CHARLES
PEROU
DIRECTOR, EXECUTIVE OFFICER
CLAY
THORP
DIRECTOR
PHASEBIO PHARMACEUTICALS INC
| CANCERGUIDE DIAGNOSTICS, INC.
| PATHFINDER THERAPEUTICS, INC.
| CLEARSIDE BIOMEDICAL, INC.
| G-ZERO THERAPEUTICS, INC.
| GENECENTRIC DIAGNOSTICS, INC.
| G1 THERAPEUTICS, INC.
| LYSOSOMAL THERAPEUTICS, INC.
| ORIG3N, INC.
| STRIDEBIO, INC.
| GENECENTRIC THERAPEUTICS, INC.
| VIGIL NEUROSCIENCE, INC.
| PIPR THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
